Montecillo, Rosindo D.

HRN: 08-12-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2025
06/15/2025
IV
500mg
Q6h
Dm Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: